AllPure Says Fed. Circ. Needn't Revisit Device Patent Ruling
AllPure Technologies Inc. has urged the Federal Circuit to reject a full-panel rehearing bid from rival EMD Millipore Corp., a unit of Merck KGaA whose device patent for withdrawing fluid from...To view the full article, register now.
Already a subscriber? Click here to view full article